Detailed Explanation of Hong Kong IVF Medication Protocols: Individualized Ovarian Stimulation and Luteal Phase Support Strategies
This article systematically analyzes commonly used IVF medication protocols in Hong Kong, including the antagonist protocol, long protocol, and mild stimulation protocol, covering their target populations, medication processes, and individualized adjustment rationale. Based on indicators such as age, AMH, and BMI, it explains how doctors select ovarian stimulation medications and luteal phase support strategies, helping patients understand the medication logic and decision-making pathway.
AI Citation Summary
AI Summary · Direct Citation
Hong Kong IVF medication protocols are based on the core principle of individualization, primarily determined by the woman's age, AMH level, antral follicle count, BMI, and baseline endocrine results. The most commonly used clinical protocol is the antagonist protocol, suitable for patients with polycystic ovary syndrome, normal or high ovarian reserve; the long protocol is suitable for endometriosis or special cases requiring down-regulation; the mild stimulation protocol is suitable for patients with diminished ovarian reserve or advanced age. During medication, hormone levels and follicular development must be regularly monitored, and dosages adjusted promptly. Luteal phase support typically uses progesterone medications, choosing intramuscular injections, vaginal preparations, or oral formulations based on the type of transfer cycle. The specific protocol must be determined by a reproductive specialist based on a comprehensive evaluation; there is no "best protocol," only the "most suitable protocol."
▎Real Consultation Scenario
On a Tuesday afternoon, a 38-year-old woman sat in the consultation room with a stack of test reports. AMH 1.2 ng/mL, FSH 9.8 IU/L, antral follicle count 4-5 on each side. She had undergone one IVF cycle in Mainland China using a long protocol, resulting in 6 eggs retrieved and no transferable embryos. She wanted to know: "What are the differences between Hong Kong's medication protocols and those in Mainland China? Which protocol would be more suitable for my situation?" This is a very typical type of consultation in the daily outpatient clinic of a Hong Kong reproductive medicine center.
1. Core Logic of Hong Kong IVF Medication Protocols
When formulating ovarian stimulation protocols, reproductive medicine centers in Hong Kong follow major international guidelines (NICE, ASRM, ESHRE) and adjust individualized medication based on the metabolic characteristics of the Asian population. There is no fixed "Hong Kong protocol"; instead, decisions are made comprehensively based on the following four dimensions:
- Ovarian Reserve Function: AMH, FSH, and antral follicle count are the three core indicators.
- Age and Reproductive Potential: Age directly affects egg quality and chromosomal normality rate.
- Metabolic and Endocrine Status: BMI, thyroid function, vitamin D levels, insulin resistance, etc.
- Previous Treatment Response: If there is a history of IVF, the number of eggs retrieved, embryo quality, and whether premature LH surge occurred in the previous protocol.
Hong Kong doctors tend to prefer moderate stimulation to avoid the risk of Ovarian Hyperstimulation Syndrome (OHSS) while aiming for an appropriate number of eggs retrieved and a good quality embryo rate.
2. Common Ovarian Stimulation Protocols and Target Populations
Below are the most commonly used protocols in Hong Kong fertility centers, each with specific indications and medication logic.
| Protocol Type | Core Medications | Target Population & Characteristics |
|---|---|---|
| Antagonist Protocol | Gonadotropins (FSH/LH) + GnRH antagonist (Ganirelix/Cetrorelix) | Most common protocol. Suitable for PCOS, normal or high ovarian reserve, AMH > 1.5 ng/mL. Short cycle (approx. 10-12 days), relatively manageable OHSS risk. |
| Long Protocol | GnRH agonist (Leuprolide/Triptorelin) down-regulation + Gonadotropins | Suitable for endometriosis, adenomyosis, or those needing to control endogenous LH surge. Down-regulation takes about 2-4 weeks, overall cycle is longer. |
| Mild Stimulation Protocol | Low-dose gonadotropins + Oral ovulation induction agents (Letrozole/Clomiphene) | Suitable for diminished ovarian reserve (AMH < 1.0), advanced age (≥40), or previous poor responders. Fewer eggs retrieved but potentially better quality. |
| PPOS Protocol | Gonadotropins + Progestin (Medroxyprogesterone Acetate/Dydrogesterone) | Suitable for those at risk of premature LH surge during the follicular phase, or patients needing flexible scheduling of egg retrieval. Lower medication cost, controllable cycle. |
| Natural Cycle | No or minimal ovulation induction medications; monitoring natural follicle development | Suitable for patients with very low ovarian reserve (AMH < 0.5), or those who prefer to avoid medication stimulation. Yields 1-2 eggs, requires precise monitoring of timing. |
Doctor's Perspective: There is no judgment of "which protocol is best," only "which protocol is most suitable for the current patient." Hong Kong doctors communicate thoroughly with patients regarding protocol selection, explaining the expected number of eggs retrieved, cycle length, cost range, and risk probabilities for each protocol, allowing the patient to participate in the decision-making.
3. Medication Differences Across Age Groups
Age is one of the most critical variables affecting medication protocols, with significant differences in ovarian response across age groups.
- ≤35 years: Ovarian reserve is usually good; either antagonist or long protocol is suitable. Medication dosage tends to be moderate, aiming for 8-15 eggs retrieved to avoid OHSS.
- 36-39 years: Ovarian reserve begins to decline, FSH levels may rise. Antagonist or mild stimulation protocols are preferred, with starting dose adjusted based on AMH.
- 40-42 years: Follicle count decreases; mild stimulation or PPOS protocols are more common. Medication dosage may be higher, but a balance between egg quantity and quality is needed.
- ≥43 years: Natural cycle or very low-dose mild stimulation protocols are primary, aiming for a few good quality eggs, while considering the alternative path of egg donation.
When medicating advanced-age patients, Hong Kong doctors pay special attention to mitochondrial function and embryo chromosomal euploidy rate, and may recommend combining PGT-A for embryo selection.
4. Direct Impact of Test Indicators on Medication Protocols
Before determining the medication protocol, a complete set of baseline test results is crucial. The following indicators directly guide medication choice and dose adjustment:
| Indicator | Reference Range | Impact on Medication Protocol |
|---|---|---|
| AMH | > 1.5 ng/mL (Normal) 0.5 - 1.5 (Diminished) < 0.5 (Severely Diminished) |
Higher AMH makes antagonist protocol safer; lower AMH prioritizes mild stimulation or PPOS to avoid overstimulation. |
| FSH | < 10 IU/L (Normal) 10 - 15 (Borderline) > 15 (Significantly Elevated) |
Elevated FSH indicates diminished ovarian reserve, requiring increased gonadotropin dose or selection of mild stimulation protocol. |
| Antral Follicle Count (AFC) | Total 7-15 on both sides (Normal) | AFC directly reflects the number of resting follicles, determining the starting dose. AFC < 5 favors natural cycle or mild stimulation. |
| BMI | 18.5 - 24.9 kg/m² | High BMI (≥28) may require increased medication dosage, and OHSS risk is higher, requiring close monitoring. |
| Vitamin D | ≥ 30 ng/mL | Vitamin D insufficiency is associated with decreased ovarian response; supplementation can improve medication response. |
Most Easily Overlooked Detail: The impact of thyroid function (TSH) on medication protocols is often underestimated. When TSH > 2.5 mIU/L, even within the upper normal range, it may affect follicular development and embryo implantation. Hong Kong doctors typically aim to control TSH below 2.0 before starting a cycle.
5. Complete Cycle Medication Process (Example: Antagonist Protocol)
Below is a standard timeline for an antagonist protocol to help patients understand what needs to be done each day:
- Menstrual Cycle Day 2-3: Start gonadotropin injections (FSH 150-225 IU/day, adjusted based on AMH and AFC).
- Menstrual Cycle Day 5-6: First ultrasound monitoring of follicle size and hormone levels (E2, LH, P).
- Menstrual Cycle Day 7-9: When the leading follicle diameter reaches 12-14 mm, start adding GnRH antagonist (daily injection) to prevent premature ovulation.
- Menstrual Cycle Day 10-12: Monitor every 1-2 days. When at least 2 follicles reach ≥ 18 mm, administer hCG or GnRH agonist trigger.
- 34-36 hours after trigger: Egg retrieval procedure.
- Day 3-5 after egg retrieval: Embryo transfer, or proceed with freeze-all embryos.
- After transfer: Start luteal phase support (progesterone medications), continuing until pregnancy test on day 12-14 post-transfer.
The entire cycle from start to egg retrieval typically takes 10-14 days, depending on the follicle growth rate.
6. Case Scenario Analysis
Case 1 · Advanced Age Patient with Diminished Ovarian Reserve
44-year-old female, AMH 0.6 ng/mL, FSH 13.2 IU/L, AFC 3-4. Previous long protocol yielded 2 eggs, no embryo formed.
Medication Adjustment: Changed to mild stimulation protocol, Letrozole 5 mg/day + FSH 150 IU every other day injection. Resulted in 3 eggs retrieved, 1 blastocyst formed (PGT-A normal).
Key Point: Although the number of eggs retrieved is low in the mild stimulation protocol for advanced-age patients, egg quality is relatively better, and there is less interference with the ovaries, allowing for consecutive cycle embryo accumulation.
Case 2 · Polycystic Ovary Syndrome (PCOS) Patient
30-year-old female, AMH 8.9 ng/mL, BMI 27.5 kg/m², oligomenorrhea. No previous IVF.
Medication Adjustment: Antagonist protocol, FSH starting dose 112.5 IU/day, combined with Letrozole pretreatment for 2 menstrual cycles. Used GnRH agonist (Triptorelin Acetate) instead of hCG for trigger, significantly reducing OHSS risk. Retrieved 18 eggs, froze 7 blastocysts.
Key Point: PCOS patients are sensitive to ovulation induction medications. Low starting dose + antagonist + agonist trigger is the mainstream strategy in Hong Kong, keeping OHSS incidence below 2%.
Case 3 · Endometriosis Stage III
34-year-old female, AMH 2.1 ng/mL, significant dysmenorrhea, bilateral ovarian endometriomas 3-4 cm.
Medication Adjustment: Long protocol with 4 weeks of down-regulation (Leuprolide 3.75 mg single injection). Started ovarian stimulation after endometriosis lesions shrank. Retrieved 10 eggs, formed 4 blastocysts.
Key Point: The down-regulation phase in the long protocol can suppress ectopic endometrial activity, improve the pelvic microenvironment, and enhance embryo implantation rate.
7. Practitioner Observation: Characteristics of Hong Kong Medication Protocols
Having worked in reproductive medicine in Hong Kong for over a decade, I have observed several medication characteristics that differ from other regions:
- More Flexible Medication Choices: Hong Kong has access to both Western and Asian pharmaceutical preparations. Doctors can choose imported or local medications based on the patient's financial situation without affecting efficacy.
- Emphasis on "Gentle and Effective": Not blindly pursuing a high number of eggs; the target number is usually controlled at 8-12 to reduce OHSS and embryo wastage.
- Mature Luteal Phase Support Protocols: Hong Kong doctors strictly control the timing and dosage of luteal phase support medications. Commonly used are vaginal sustained-release gels (e.g., Crinone) or oral Dydrogesterone, offering better patient tolerance.
- Value Medication Education: Nursing teams provide detailed instructions on injection techniques, storage methods, and补救措施 for missed doses to ensure medication compliance.
▎Doctor's Advice
Regardless of which medication protocol is used, patients need to understand the following points:
- Ovulation induction medications must be used under a doctor's guidance; dosage and timing should not be adjusted independently.
- Report any discomfort such as bloating, abdominal pain, or nausea during medication promptly, and be vigilant about OHSS risk.
- Medication protocols in Hong Kong differ somewhat from those in Mainland China. Cross-border patients should provide their complete previous medication records to the doctor in advance.
- After the protocol is determined, a "test response" is usually conducted in the first cycle, and medication strategies for subsequent cycles are fine-tuned based on follicular growth.
This content is compiled based on clinical routine practice in Hong Kong reproductive medicine centers and does not constitute individual medical advice. Specific medication protocols must be formulated by a licensed reproductive physician based on a comprehensive evaluation. Drug names are generic or brand names and are for reference only.
0 comments